Post-Doctoral Research Fellow- Lab of Dr. Christine Eischen- Cancer Biology

The Eischen Laboratory utilizes multiple advanced approaches to study molecular, biochemical, immunological, and/or genetic mechanisms of cancer cell survival and growth with the goal of identifying potential targetable vulnerabilities in both hematologic and solid tumors. Our multi-disciplinary research investigates several aggressive, challenging to treat, and high relapse rate cancers, specifically lymphomas, triple negative breast, high grade serous ovarian, and oral squamous cell carcinoma.

Current available projects for postdoctoral fellows include studying the 1) immunological effects of targeted degradation of oncogenic drivers of cancers (priority project), 2) integrating targeted approaches for cancer cell vulnerabilities and overcoming survival mechanisms, and 3) global and specific protein and cellular consequences with targeted loss of specific E3 ligases.

We seek postdoctoral fellows who will be defending their PhD or MD/PhD soon or have graduated within the last 1.5 years. The ideal candidate will have demonstrated:

High motivation and commitment to research
Experience with at least two of immunological, molecular, biochemical, mouse, and/or in vitro patient cell models. (It is advantageous to have tumor immune microenvironment and/or tumor immunology research experience.)
Ability to work independently and effectively collaborate in a team
Record of peer-reviewed publications
Strong verbal and written communication
The outstanding postdoctoral training environment includes strong mentorship and career development, interdisciplinary collaborations, state-of-the-art core facilities as well as publishing consequential manuscripts, pursuing fellowship funding, and support for independent research directions.

Interested individuals should send a cover letter describing their research interests, a current CV, and contact information for 3 references to Dr. Eischen at christine.eischen@jefferson.edu. Applicants must be currently approved to work in the U.S. and be skilled in cancer research techniques. Preference will be given to applicants that are NIH training grant eligible.

Internship at The White House Office of Science and Technology

Posted: 02/05/2026

About the Company/Organization:

The White House Office of Science and Technology
Type: Other
Size:
https://www.whitehouse.gov/ostp/

Congress established the Office of Science and Technology Policy (OSTP) in 1976 to provide the President and Executive Office of the President (EOP) with advice on the scientific, engineering, and technological aspects of national policy and the work of the executive branch. This includes matters of the economy, national security, homeland security, health, foreign relations, the environment, education, and resource management.

The OSTP Director oversees the development and execution of the nation’s science and technology policy agenda, leading White House efforts in critical and emerging technologies such as artificial intelligence, quantum information sciences, and biotechnology, with the aim of safeguarding US leadership in these fields and ensuring they advance in ways that bolster American economic competitiveness, national security, and human flourishing. The OSTP Director co-chairs the President’s Council of Advisors on Science and Technology (PCAST), an advisory board whose members are drawn from outside the Federal Government, typically from industry, academia, and research institutions. The Director also chairs the National Science and Technology Council (NSTC), which coordinates the science and technology policymaking process across the executive branch to ensure delivery of the President’s agenda.

In addition to leading interagency science and policy coordination, OSTP assists the Office of Management and Budget (OMB) with annual reviews and priority setting for the Federal research and development budget, and evaluates the scale, quality, and effectiveness of Federal science and technology efforts. OSTP also serves as a source of scientific and technical analysis and judgment for the President with respect to any major strategies, plans, and Government programs.

Internship Project/Opportunity

Location: Washington DC
Anticipated internship dates: Year round
Target intern experience level: Undergraduate Students, Graduate Students
https://www.whitehouse.gov/ostp/internships/

The White House Office of Science and Technology Policy Internship Program

Serving as an OSTP Intern provides students a unique opportunity to work closely with senior White House officials and science and technology staff in OSTP’s policy divisions or on OSTP’s legal team.

More information about the application process can be found here: https://www.whitehouse.gov/wp-content/uploads/2026/01/OSTP-Intern-2026-Guidance.pdf

Policy Internships
Students interested in working on the development of national science and technology policy are recommended to apply for a policy internship. Ideal candidates have a passion for science and technology, strong research and writing skills, the ability to work while prioritizing several projects at once, a willingness to support outreach events and a desire for public service. Policy internships are open to interested students from all majors and academic programs. Any student, including law students, may apply for a policy internship.

Internships are also available with OSTP’s communications team. Students interested in Communications or Public Affairs should inquire about opportunities to work primarily with OSTP’s communications team in their policy application.

Policy internship applications only should be sent to: internships@ostp.eop.gov
Questions about your policy internship application should be sent to: internships@ostp.eop.gov

Eligibility
All applicants must be U.S. citizens. Permanent residents and students who do not currently hold U.S. citizenship are not eligible.
Applicants must be enrolled, at least half-time, in an accredited college or university during the desired internship term. Students in undergraduate, graduate, law, LLM, and professional programs in all fields are encouraged to apply.
Preference will be given to applicants available for 30+ hours per week.

Timeline
Summer Semester (May – August): Applications due February 28, 2026
Fall Semester (September – December): Applications due June 14, 2026
Spring Semester (January – April): Applications due September 20, 2026

Contact: Email

Robert Mikulak

Ambassador (ret) Robert P. Mikulak is an independent expert on chemical and biological security issues. Until mid-December 2025, he served as an expert on these issues at the United States Department of State, focusing on measures for strengthening the Biological Weapons Convention, ensuring that advances in biology are not used to create new biological weapons, and investigation of alleged use of chemical or biological weapons. He is also an expert consultant for the UN Office of Disarmament Affairs.
From November 2010 until his retirement in July 2015, Ambassador Mikulak was the United States Permanent Representative to the Organization for the Prohibition of Chemical Weapons (OPCW). He previously served in the State Department and the U.S. Arms Control and Disarmament Agency in a series of increasingly responsible technical and policy positions related to prohibition of chemical and biological weapons. During the decade-long negotiation of the 1992 Chemical Weapons Convention, he was the deputy U.S. negotiator and senior U.S. expert.
Ambassador Mikulak was awarded the OPCW-The Hague Award in 2019 for outstanding contributions toward a world free of chemical weapons. Other honors include high-level awards from the Secretaries of State and Defense and the American Association for the Advancement of Science.
Ambassador Mikulak received his undergraduate degree in chemistry at Hamline University in St. Paul, Minnesota and his Ph.D. in organic chemistry from the Massachusetts Institute of Technology. He did post-doctoral research at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany and the Massachusetts Institute of Technology.

Allen Liu

Allen Liu received a B.Sc. degree in Biochemistry (Honors) from the University of British Columbia in 2001. He obtained his Ph.D. in Biophysics in 2007 from the University of California-Berkeley and received his post-doctoral training at The Scripps Research Institute-La Jolla. He started his group in 2012, and he is currently the Associate Chair for Graduate Education and a Professor in Mechanical Engineering, Biomedical Engineering, and Biophysics at the University of Michigan. His current research interests lie in cellular mechanotransduction and bottom-up synthetic biology, and his lab uses tools from quantitative cell biology, synthetic biology, biophysics, and microfluidics. He has received the NIH Director’s New Innovator Award, a Young Innovator by Cellular and Molecular Bioengineering (CMBE), a Rising Star from CMBE-Biomedical Engineering Society (BMES), and was named a Future of Biophysics Burroughs Wellcome Fund Symposium speaker. He is an elected Fellow of the BMES, and a recipient of the Endeavour Executive Fellowship (Australia) and the Alexander von Humboldt Fellowship for Experienced Researcher (Germany)

Synthetic Biology and Engineering Organisms for the Environment

What are engineered microbes? How are they created? And why are scientists developing them? In this lecture, Joff Silberg, Ph.D., Professor of Biosciences at Rice University, will describe what synthetic biology is and how it can be used to develop engineered microbes that have new functions that can identify disease outbreaks, breakdown chemicals, and develop more sustainable fertilizers.

This event is part of the “Engineered Microbes for Environmental Release” webinar series that brings together voices from synthetic biology, ecology, policy, science and technology studies, biotechnology, ethics, and history to explore the social, technological, and environmental dimensions of these innovations. Hosted by the Baker Institute’s Science and Technology Policy Program and co-sponsored by the Rice Synthetic Biology Institute, this webinar series was supported by a grant from Schmidt Sciences and the National Science Foundation (#2223678 & 2515431).

Alejandro Vallejo

I am a biotechnologist and biosecurity specialist with active research and policy engagement at the intersection of synthetic biology, public health, and regulatory governance. My work combines molecular biology, genomics, and bioethics with the development and evaluation of biosafety and biotechnology regulatory frameworks in Latin America and the Caribbean. I have published peer-reviewed research on genomics, molecular diagnostics, and emerging biotechnologies, and I served as a national consultant on biosecurity for international organizations including FAO and PAHO/WHO and National organizations like the Ministry of Environment. My professional focus is on enabling responsible innovation in synthetic biology through evidence-based policy, capacity building, and applied research in resource-limited settings.

Rennos Fragkoudis

Rennos Fragkoudis completed his PhD on molecular virology and viral pathogenesis at the University of Edinburgh and for ~15 years he concentrated his research on the pathogenesis of arthropod-borne viruses (arboviruses) in both vertebrate and invertebrate systems working with alpha-, flavi- and bunyaviruses.
Since November 2019, Rennos is the Head of the Edinburgh Genome Foundry at the University of Edinburgh’s School of Biological Sciences. In this role, he leads a multidisciplinary team focused on advancing high-throughput Engineering Biology through the innovative application of laboratory automation and robotics. Under his leadership, the Edinburgh Genome Foundry has become a hub for automated Engineering Biology, fostering collaboration across academia and industry and working on a large variety of projects addressing grand challenges.

Susan Rosser

Susan is Professor of Synthetic Biology and Royal Academy of Engineering (RAEng) Chair in Emerging Technologies at the University of Edinburgh. She was Director of the UK Centre for Mammalian Synthetic Biology and is currently the director of the newly funded Engineering Biology Mission Hub for Advanced Therapeutics. Prof Rosser is Co-director of the Edinburgh Genome Foundry for synthetic DNA assembly and cell phenotyping. Her research focuses on using engineering biology approaches for developing and controlling genetic circuits for applications in cell and gene therapies as well as metabolic engineering. Prof Rosser is a member of the UK Engineering Biology Advisory Panel. She is also co-founder of two early-stage start-ups using a combination of AI and engineering biology for new gene therapies and enzyme replacement therapies for rare diseases.

Seung Hwan Lee

Seung Hwan “Allen” Lee is an Assistant Professor of Chemical Engineering and Materials Science and Ray D. & Mary T. Johnson/Mayon Plastics Professor at the University of Minnesota, Twin Cities. His passion for engineering microorganisms to enable sustainable energy and chemical production began during his undergraduate research at UCLA under Prof. James Liao. After completing his undergraduate studies, he earned his Ph.D. in Chemical and Biomolecular Engineering from Rice University, where he worked under the guidance of Prof. Ramon Gonzalez. His undergraduate and doctoral research focused on the efficient biological utilization of one-carbon (C1) compounds through engineering native and synthetic metabolic pathways. As one of the co-inventors of the Formyl-CoA Elongation (FORCE) pathways, he helped develop a novel approach for converting C1 feedstock into value-added small molecules. During his postdoc under the guidance of Prof. Greg Stephanopoulos at MIT, he has expanded his research to include engineering non-model organisms, leveraging their inherent abilities to efficiently utilize C1 and C2 feedstocks. Beyond his research, Allen is actively engaged in biotechnology and climate technology communities, participating in organizations such as the Society for Industrial Microbiology and Biotechnology (SIMB), the Engineering Biology Research Consortium (EBRC), and the MIT Energy Conference.

Internship at Hoover Institution

Posted: 12/23/2025

About the Company/Organization:

Hoover Institution
Type: Nonprofit/NGO
Size:
https://www.hoover.org/

The Hoover Institution, Stanford University, is a public policy research center devoted to the advanced study of economics, politics, history, and political economy—both domestic and foreign—as well as international affairs. With its eminent scholars and world-renowned Library & Archives, the Hoover Institution seeks to improve the human condition by advancing ideas that promote economic opportunity and prosperity and secure and safeguard peace for America and all mankind.

Internship Project/Opportunity

Location: Palo Alto, CA
Anticipated internship dates: August 10-14, 2026
Target intern experience level: Undergraduate Students, Graduate Students
https://www.hoover.org/hoover-institution-summer-policy-boot-camp

The Hoover Institution’s Summer Policy Boot Camp (HISPBC) is an intensive, four-day residential immersion program in the essentials of today’s national and international United States policy. The program is intended to instruct college students and recent graduates on the economic, political, and social aspects of United States public policy. The goal is to teach students how to think critically about public policy formulation and its results.

Designed to foster fact-based critical thinking on the most important policy issues, students will have a unique chance to interact directly with the faculty of Stanford University’s Hoover Institution, comprised of world-renowned scholars in economics, government, political science, and related fields. Session topics are selected because of their immediate relevance to today’s and tomorrow’s challenges. Participants will collaborate through class discussions and study groups that encourage diverse perspectives. Enrollment is limited, in order to facilitate maximum interaction with the faculty and other participants.

Applications for the 2026 Summer Policy Boot Camp are now open.

 

Qualifications to Apply

Only those who meet one of the following requirements should move forward with this application:

  • Completed at least two years of a four-year undergraduate degree by summer 2026 (i.e., current sophomores, Juniors or seniors)
  • Completed at least two years of a three-year undergraduate degree by summer 2026 (some international applicants); or
  • Recent graduate from an undergraduate degree program (graduate students are eligible to apply).

 

Time Commitment

HISPBC requires a 100% time commitment for the duration of the four-day program, including active collaboration with study groups outside of class.

 

Cost / Tuition

The boot camp is FREE to all accepted applicants. Program fees, food and lodging will be covered for participants accepted into the program. Travel expenses and other incidentals are not included. It is FREE to apply during Early Bird Registration – after that deadline, there is a nonrefundable $100 application fee to submit an application.

 

Deadline Dates

  • November 2025 – Applications open
  • January 19, 2026 – Early Bird Registration Ends ($0 registration fee)
  • March 3, 2026 – Regular Registration & Letters of Recommendations Due ($100 nonrefundable application fee required – see payment instructions below)
  • April 8, 2026 – Admissions Notify Date

 

Application Fee Payment Instructions

When your application is ready to be submitted, pay the $100 (non-refundable) fee on Stripe and upload your receipt within the application. Use the same email for both application and payment. Stripe is a Stanford-approved third-party e-commerce platform designed to securely accept credit card payments online. Click here to submit payment.

 

Certificate of Completion

Successful participants receive a certificate of completion endorsed by Hoover Institution’s director and HISPBC’s faculty directors. To successfully complete the program, participants must:

  • Attend all sessions
  • Complete assignments and projects
  • Collaborate with their fellow participants in class discussions

For any questions related to the program, please email hispbcadmin@stanford.edu.

 

Contact: Email

Rodrigo Ledesma-Amaro

Rodrigo Ledesma-Amaro is a Professor at Imperial College London, where he leads a research group working on Engineering Biology and sustainability. He is the director of the Bezos Centre for Sustainable Proteins and the Microbial Food Hub. His research focuses on the use of microorganisms to convert renewable feedstocks into valuable products (such as food ingredients). He has published over 200 articles, most on topics related to microbial bioproduction (precision, biomass and traditional fermentation).
Rodrigo obtained his PhD at the University of Salamanca (Spain). Before joining Imperial, he carried out his postdoctoral research at the National Research Institute for Agriculture, Food and the Environment (INRAE, France). He has been a visiting researcher at Chalmers University of Technology (Sweden) and AIST (Japan).

Joshua Wentzel

Josh Wentzel is the Assistant Director of the Biosecurity and Pandemic Policy Center, part of the Scowcroft Institute for International Affairs at the Texas A&M Bush School of Government & Public Service.​ Based at the Bush School DC, Josh has six years of experience working in Congress, where he spent time in both chambers, working in the House and on the Senate Committee on Health, Education, Labor and Pensions (HELP) working on pandemic preparedness, stockpiling, and biosecurity issues. During the COVID-19 pandemic response, Josh joined the U.S. Department of Health and Human Services, working closely with the Assistant Secretary for Preparedness and Response (ASPR) on distribution of COVID-19 medical countermeasures, daily situational awareness reports, and ASPR testimony to Congress and communication with State and Local governments. He holds a BA in International Studies from Emory University and an MS in Biohazardous Threat Agents and Emerging Infectious Diseases from Georgetown University.

Internship at Genentech

Posted: 11/25/2025

About the Company/Organization:

Genentech
Type: Company
Size:
https://www.gene.com/

Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.

To solve the world’s most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.

We celebrate our unique history as the pioneers of scientific breakthroughs that have an incredible track record of improving lives. And yet, our ambitions are bigger and bolder. We are growing a team committed to the bold quest to solve the world’s most complex health challenges.

Joining Genentech means embracing a shared identity as a changemaker.

Internship Project/Opportunity

Location: Oceanside, CA
Anticipated internship dates: Between May and June 2026
Target intern experience level: Undergraduate Students
https://careers.gene.com/us/en/job/202511-129927/2026-Summer-Genentech-Community-College-Internship-Program-Manufacturing

 

Department Summary

We are now accepting applications for the Summer 2026 Genentech Community College Internship Program. This post is for manufacturing-based roles in Oceanside, CA. There are separate posts for other roles in South San Francisco, CA. Our program is designed to expose students from community colleges to STEM career paths. The goal of the program is to train entry-level candidates with skills that will enable them pursue a career in the biopharma industry.

This internship is located in Oceanside, CA.

 

The Opportunity

As an intern, you will perform various tasks under the guidance and mentorship of your manager. You will be expected to attend meetings, read independently on relevant topics, follow a training schedule set by your supervisor, and perform tasks independently as appropriate. You will also be expected to summarize the purpose of your work and any findings, and you will present future recommendations in the form of an oral and poster presentation.

 

Program Highlights

  • Intensive 12-weeks, full time (40 hours per week) paid internship.
  • Program start dates are between May and June 2026.
  • A stipend, based on location, will be provided to help alleviate costs associated with the internship.
  • Ownership of impactful business-critical projects.
  • Work with some of the most talented people in the biotechnology and pharmaceutical industries.
  • Final presentations of project work to senior leaders.
  • Professional & personal development curriculum throughout the program, such as networking opportunities, workshops, tours, and panel discussions.

 

Who You Are

  • Education Level: Community college affiliate (currently enrolled at a community college OR terminal A.S./A.A. degree holder within 1.5 years post-graduation at the time of application).
  • Applicants must be age 18 or older for this opportunity.
  • Must have a high school diploma or GED at the time of application.
  • Preferred Majors/Coursework: STEM major with coursework in Biomanufacturing, Biotechnology, Biology, Chemistry, Bioengineering, or similar.

 

Other Qualifications

  • Outstanding communication, collaboration, interpersonal, and problem-solving skills.
  • Integrity, Courage, and Passion that complements our company culture.
  • Interest in a STEM career, preferably in biotech/pharma.
  • Careful, detail-oriented working style.
  • Commitment to being trained in a new area and asking questions to support learning.
  • Adaptive learner who can adjust to change easily.

 

Preferred (but not mandatory) skills:

Please note: The goal of the internship will be to train you. The following skills will give you an idea of different opportunities. You do NOT need to have all of these skills in order to apply. Not all internships will use all these skills.

  • Pipetting and wet lab measurements: how to use a scale, volumetric flasks, or graduated cylinders.
  • Understanding of chemistry calculations: determine molarity, % Volume, or how to calculate for dilutions.
  • Familiarity with mammalian cell culture and aseptic techniques.
  • Familiarity with bioreactors.
  • Familiarity with spreadsheets like Microsoft Excel with a basic understanding of how to organize data and use them to do calculations.
  • Experience with presentations using programs like Google Slides or PowerPoint.
  • Time management: organizing to-do lists, setting priorities, and following through to meet goals and deadlines.
  • Experience with organizational software: Google calendar or others.

Relocation benefits are not available for this job posting.

The expected salary range for this position based on the primary location of California is $23.00-$25.00 per hour. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. This position also qualifies for paid holiday time off benefits.

Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company’s policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws.

If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants.

 

To Apply

Submit a cover letter and a one-page resume that explains how a Genentech internship will make a difference in your learning journey and why you are qualified. Highlight any plans for your education/career and challenges you have overcome. Be bold, and most importantly, be you.

Internship at Zoetis

Posted: 11/21/2025

About the Company/Organization:

Zoetis
Type: Company
Size: 10,000
https://www.zoetis.com/

The world’s leading animal health company. Zoetis has been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries.

Internship Project/Opportunity

Location: Several locations throughout the U.S. (see individual postings)
Anticipated internship dates: May-August 2026
Target intern experience level: Undergraduate Students, Graduate Students
https://zoetis.wd5.myworkdayjobs.com/zoetis_intern

The Zoetis Summer Intern Program offers students the opportunity to gain real-world experience in our award-winning culture, grounded in our Core Beliefs. Our summer internships typically occur in the May-August timeframe and openings are posted in the fall of each year.

Our Summer Internship Program provides you with an opportunity to gain hands-on experience in the unique industry of animal health in a supportive and collaborative environment as well as:

  • Build on your education with real world experiences
  • Establish relationships and learn from talented professionals at an award-winning company
  • Contribute to our greater purpose: work on meaningful projects that help us nurture the world and humankind by advancing the care of animals
  • Competitive pay
  • Fun!

 

Qualifications:

  • Enrolled in a degree program during the spring term preceding internship
  • Completion of at least one year of undergraduate studies and a 3.0 GPA or higher
  • At least 18 years of age and authorized to work in the U.S.
  • Successfully pass a background check and drug screen
  • Strong communication, interpersonal, organizational, problem solving & analytical skills

 

Contact: Email

Mark Bathe

Mark Bathe is a Professor in the Department of Biological Engineering at MIT, a Member of the Harvard Medical School Initiative for RNA Medicine, and an Associate Member of the Broad Institute of MIT & Harvard. He obtained his Doctoral Degree at MIT working in the Departments of Biological, Chemical, and Mechanical Engineering before moving to the University of Munich for his postdoctoral research in Biological Physics. He returned to MIT in 2009 to join the faculty in the Department of Biological Engineering, where he runs an interdisciplinary research group focused on engineering nucleic acids for the targeted delivery of therapeutics and vaccines, phenotypic profiling of neuronal circuits, and molecular computing and data storage. He is academic co-founder of Cache DNA and Kano Therapeutics, and in his free time he enjoys running, biking, swimming, and skiing, amongst other outdoor activities.

Xu Zhang

Dr. Zhang’s work integrates genetic engineering, electrochemistry, and device design to develop living microbial systems for bioelectronics and functional biomaterials.

Christian Euler

I am a metabolic engineer and systems biologist with research interests primarily focused on finding/developing novel biological pathways for waste upcycling. My group does “full stack” metabolic engineering, from in silico modelling and design through to bench-scale fermentation to evaluate scalability. I am also the co-founder of Phycus Biotechnologies, which makes bio-based glycolic acid using a novel, sustainable fermentation process.

NextGen Omics, Spatial & Data UK 2025

The NextGen Omics, Spatial & Data UK event, now in its 18th year, unites the multi-omics, spatial biology, and data science communities. Held annually in London, it serves as a key meeting point for influential researchers, healthcare leaders, and technology innovators from the UK and Europe. The event aims to address the complexity of interpreting and integrating multi-omics data by fostering dialogue, sharing best practices, and inspiring cross-sector collaboration among teams from academia, pharma, and biotech, ultimately aiming to accelerate the development of life-saving treatments for patients.

Alberto Donayre

Dr. Alberto J. Donayre-Torres is a Professor in the Department of Bioengineering at Universidad de Ingeniería y Tecnología (UTEC) in Lima, Peru. He holds a Ph.D. in Plant Genetics and Biotechnology from CINVESTAV-IPN, Mexico (2009), and completed postdoctoral training at the National Autonomous University of Mexico (UNAM) and Colorado State University (USA), where he spent five years advancing synthetic biology platforms for programmable biological systems. His research sits at the convergence of synthetic biology, advancing biomaterials using bioconjugation engineering (ACS Omega, 2025). He leads projects developing open-source tools for DNA assembly (pyBrick-DNA, J. Comp. Biol., 2023) and develops international collaboration on predictive biomaterial modeling AI-assisted. Dr. Donayre has supervised undergraduate and graduate research in recombinant protein synthesis, hydrogel functionalization, and bioconjugation — and actively contributes to the global synthetic biology community as co-organizer of international congresses and developer of open bioengineering platforms.

Joy Y. Zhang

Joy Y. Zhang is a Professor of Sociology and Founding Director of the Centre for Global Science and Epistemic Justice (GSEJ) at the University of Kent. Her research examines evolving science–society dynamics and their implications for the global ethical governance of emerging life sciences. Conceptually, her work advances the theorisation of cosmopolitanisation, decolonisation, commoning, epistemic justice, and subaltern politics. Empirically, her research focuses on four major scientific powers—China, India, the UK, and the US. She has studied the governance and science diplomacy of emerging life sciences—including stem cells, synthetic biology, genome editing, and experimental therapies—alongside climate politics, food movements, and environmental engineering. She currently leads three cutting-edge social research programmes on engineering biology and its applications in critical minerals, biomedicine, and agriculture, with the aim of informing social and policy deliberation in the UK and internationally. She is the author of three academic books and publishes widely in high-impact journals across the natural and social sciences. She is frequently interviewed by global media and advises leading research and policy institutions in Europe and Asia.